A three-part model for the self-controlled case series design to estimate and characterize adverse event risk in an overlapping risk period after multiple vaccines: application to ischemic stroke following Pfizer-BioNTech bivalent COVID-19 vaccine and influenza vaccine

Journal:

American Journal of Epidemiology

Published:

2025-06-04

DOI:

10.1093/aje/kwaf115

Affiliations:

4

Authors:

9

Go to article

Institutions	Authors	Share
Kaiser Permanente Southern California, United States of America (USA)	7.500000	0.83
Kaiser Permanente Bernard J. Tyson School of Medicine, United States of America (USA)	1.000000	0.11
The University of Alabama at Birmingham (UAB), United States of America (USA)	0.500000	0.06

Interested in Clinical Sciences?